Cardiff Oncology Inc (CRDF)

NASDAQ
3.160
+0.050(+1.61%)
After Hours
3.120
-0.040(-1.266%)
- Real-time Data
  • Volume:
    937,206
  • Bid/Ask:
    3.120/3.160
  • Day's Range:
    3.025 - 3.190

CRDF Overview

Prev. Close
3.11
Day's Range
3.025-3.19
Revenue
350K
Open
3.1
52 wk Range
3.025-14.97
EPS
-0.67
Volume
937,206
Market Cap
132.61M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,020,191
P/E Ratio
-
Beta
1.9
1-Year Change
-72.77%
Shares Outstanding
41,963,704
Next Earnings Date
10 Mar 2022
What is your sentiment on Cardiff Oncology Inc?
or
Market is currently closed. Voting is open during market hours.

Cardiff Oncology Inc Company Profile

Employees
0

Cardiff Oncology Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatment for cancer patients. Its drug candidate includes onvansertib , which is a novel polo-like kinase 1 (PLK1) adenosine triphosphate (ATP) competitive inhibitor with the combination of chemotherapy and targeted therapeutics. The Company's clinical trail includes TROV-052 , a Phase I b/2 open-label clinical trial of onvansertib in combination with standard-of-care low-dose cytarabine (LDAC) , TROV-053 a Phase II open-label clinical trial of onvansertib in combination with Zytiga (abiraterone acetate)/prednisone and TROV-054 a Phase I b/2 open-label clinical trial of onvansertib in combination with FOLFIRI (folinic acid, fluorouracil, and irinotecan) and Avastin (bevacizumab). Its clinical development programs include tumor genomics and biomarker technology to enable assessment of patient response to treatment.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuySellStrong SellStrong Sell
SummaryStrong BuyStrong BuySellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.